Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03295071 · ClinicalTrials.gov registry record
REALITY LHON Registry
A clinical trial, sponsored by GenSight Biologics.
- Completed
- Registry status
- 44
- Enrollment target
NCT03295071 is a clinical trial that has completed, run by GenSight Biologics. The registered enrollment target is 44 participants.
The verdict
NCT03295071 has completed, sponsored by GenSight Biologics.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
This study is a multi-country retrospective and cross-sectional observational study of affected LHON subjects, based on retrospective subjects' medical chart abstractions and cross-sectional administration of patient-reported outcomes (PROs).
Interventions
- OTHER Patient-reported outcomes (PROs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2018-01-03 |
| Est. Completion | 2020-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03295071
The ClinicalTrials.gov registry entry for NCT03295071 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GenSight Biologics, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Patient-reported outcomes (PROs) is the first listed.
NCT03295071 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03295071 about?
NCT03295071 is a clinical study titled "REALITY LHON Registry". This study is a multi-country retrospective and cross-sectional observational study of affected LHON subjects, based on retrospective subjects' medical chart abstractions and cross-sectional administration of patient-reported outcomes (PROs).
What is the current status of trial NCT03295071?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2018-01-03. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT03295071?
The interventions under investigation include: Patient-reported outcomes (PROs) (OTHER).
Who is sponsoring clinical trial NCT03295071?
This trial is sponsored by GenSight Biologics, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.